Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 83 of 3073 for:    Recruiting, Not yet recruiting, Available Studies | Physical

Acute Cycling on Executive Control (ACE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03499977
Recruitment Status : Not yet recruiting
First Posted : April 17, 2018
Last Update Posted : June 21, 2018
Sponsor:
Information provided by (Responsible Party):
Dr. Harry Prapavessis, Western University, Canada

Tracking Information
First Submitted Date  ICMJE April 9, 2018
First Posted Date  ICMJE April 17, 2018
Last Update Posted Date June 21, 2018
Estimated Study Start Date  ICMJE July 1, 2018
Estimated Primary Completion Date December 31, 2018   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures  ICMJE
 (submitted: April 9, 2018)
  • Reaction Time [ Time Frame: 30 minutes ]
    Time in milliseconds to target
  • Accuracy [ Time Frame: 30 minutes ]
    Directional errors
Original Primary Outcome Measures  ICMJE Same as current
Change History Complete list of historical versions of study NCT03499977 on ClinicalTrials.gov Archive Site
Current Secondary Outcome Measures  ICMJE Not Provided
Original Secondary Outcome Measures  ICMJE Not Provided
Current Other Pre-specified Outcome Measures
 (submitted: April 9, 2018)
Heart Rate [ Time Frame: 10 minutes ]
Heart rate measured in beats per minute with a Polar Heart Rate Monitor as a manipulation check
Original Other Pre-specified Outcome Measures Same as current
 
Descriptive Information
Brief Title  ICMJE Acute Cycling on Executive Control
Official Title  ICMJE The Effects of Acute Cycling on Executive Control
Brief Summary This study will examine whether 10-minute bouts of cycling at various intensities will impact executive functioning (i.e., cognitive ability) as assessed by the antisaccade (AS) task through a total of five visits. An antisaccade is a rapid eye movement away from a visual target. The ability to suppress making an eye movement towards a visual target gauges inhibitory control (i.e., a domain of executive functioning). In the initial visit, participants' exercise capacity will be assessed through a maximal effort cycling test. Intensities for the cycling bouts (i.e., high, moderate, low) in subsequent sessions will be based upon this maximal effort cycling test. In visits 2 through 5, participants will complete an AS task, followed by a 10-minute bout of cycling, and then complete the AS task again. The order of cycling intensities will be randomized between participants. Differences in the AS task (i.e., reaction time and accuracy) will be compared between and within cycling conditions.
Detailed Description Not Provided
Study Type  ICMJE Interventional
Study Phase  ICMJE Not Applicable
Study Design  ICMJE Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: None (Open Label)
Primary Purpose: Basic Science
Condition  ICMJE Physical Activity
Intervention  ICMJE
  • Behavioral: Sitting
    10 min bouts
  • Behavioral: Light-Intensity Cycling
    10min bout
  • Behavioral: Moderate-Intensity Cycling
    10 min bout
  • Behavioral: High-Intensity Cycling
    10 min bout
Study Arms  ICMJE
  • Experimental: Sitting
    The participant will be asked to sit for 10 min (not increasing their heart rate) then do the anti-saccade task
    Intervention: Behavioral: Sitting
  • Experimental: Low-Intensity Cycling
    Participant will be asked to cycle for 10 min (<40% VO2R) and then perform the anti-saccade task
    Intervention: Behavioral: Light-Intensity Cycling
  • Experimental: Moderate-Intensity Cycling
    The participant will be asked to do 10 min of cycling (40-59% VO2R) followed but the anti-saccade task
    Intervention: Behavioral: Moderate-Intensity Cycling
  • Experimental: High-Intensity Cycling
    The participant will be asked to do 10 min of cycling (60%-84% VO2R) followed but the anti-saccade task
    Intervention: Behavioral: High-Intensity Cycling
Publications * Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status  ICMJE Not yet recruiting
Estimated Enrollment  ICMJE
 (submitted: April 9, 2018)
20
Original Estimated Enrollment  ICMJE Same as current
Estimated Study Completion Date  ICMJE July 31, 2019
Estimated Primary Completion Date December 31, 2018   (Final data collection date for primary outcome measure)
Eligibility Criteria  ICMJE

Inclusion Criteria:

  • Able to read, write and understand English
  • Full time student enrolled at Western University
  • Able to perform a ten-minute exercise task at a light intensity without health implications
  • Have email or phone number for contacting purposes

Exclusion Criteria:

  • Do not have a medical condition that prevents you from exercise (e.g. heart attack in the past year, heart disease, irregular heartbeat, etc.)
  • Do not have history of eye injury or neurological impairment
  • Do not have an orthopaedic limitation
  • Are not pregnant
Sex/Gender  ICMJE
Sexes Eligible for Study: All
Ages  ICMJE 18 Years to 64 Years   (Adult)
Accepts Healthy Volunteers  ICMJE Yes
Contacts  ICMJE
Contact: Harry Prapavessis, Ph.D 5196612111 ext 80173 hprapave@uwo.ca
Contact: Kirsten B Dillon, B.Sc 6043566359 kdillon9@uwo.ca
Listed Location Countries  ICMJE Canada
Removed Location Countries  
 
Administrative Information
NCT Number  ICMJE NCT03499977
Other Study ID Numbers  ICMJE PA and Executive Functioning
Has Data Monitoring Committee Not Provided
U.S. FDA-regulated Product
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
IPD Sharing Statement  ICMJE
Plan to Share IPD: No
Responsible Party Dr. Harry Prapavessis, Western University, Canada
Study Sponsor  ICMJE Western University, Canada
Collaborators  ICMJE Not Provided
Investigators  ICMJE
Principal Investigator: Harry Prapavessis, Ph.D Western University
PRS Account Western University, Canada
Verification Date June 2018

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP